Answers are grounded in this paper and cite their sources.
BACKGROUND: Enhanced recovery after surgery (ERAS) pathways have reduced inpatient opioid exposure after posterior spinal fusion (PSF) for adolescent idiopathic scoliosis (AIS), yet the discharge prescription has received far less scrutiny. Temporal trends in prescription size, caregiver-reported consumption, and household disposal of unused medication remain poorly characterized. METHODS: This retrospective study included 321 patients aged 10 to 20 years undergoing primary PSF for AIS from 2018 to 19 through 2024 to 25 at a single tertiary pediatric hospital. Prescribing among 275 patients discharged with tablets was modeled with multivariable linear regression. Caregiver-reported pill counts from a postoperative survey (consumption cohort, n=79; telephone era, n=36; text-message era, n=43) informed consumption and waste analyses; disposal and home pain-management items came from all respondents (n=91 to 115 per item). Sensitivity analyses addressed pathway timing, survey modality, response bias, and missing pill counts among families still taking opioids. RESULTS: Median tablets prescribed declined 67%, from 55 to 18 (adjusted β=-4.91 tablets/year; 95% CI, -5.53 to -4.29; P<0.001), beginning before the most recent ERAS pathway. Reported consumption declined from a median of 30 to 7 tablets, but this decline could not be separated from the survey modality change (telephone era only, P=0.69). The median unused proportion rose from 10% to 40% (unadjusted β=+4.6 percentage points/year; P=0.004) but not significantly after adjustment (P=0.056) or when families still taking opioids were assumed to use their full prescription. Among families with leftover opioids, 22% reported disposal. Requests for additional pain medication (18%) and satisfaction (93%) did not differ between survey eras. CONCLUSIONS: Discharge opioid prescribing after PSF for AIS declined substantially over 7 years without an apparent change in home pain-management outcomes. Consumption and waste estimates are less certain because they rest on a small, survey-dependent cohort. A default prescription near 15 tablets is a hypothesis for prospective testing, and routine disposal kits at discharge warrant evaluation. LEVEL OF EVIDENCE: Level IV-therapeutic study.
No takes yet. Share an insight, caveat, or question.
Gamadia et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: